Molecular dynamics simulations suggest possible activation and deactivation pathways in the hERG channel
- PMID: 35210539
- PMCID: PMC8873449
- DOI: 10.1038/s42003-022-03074-9
Molecular dynamics simulations suggest possible activation and deactivation pathways in the hERG channel
Abstract
The elusive activation/deactivation mechanism of hERG is investigated, a voltage-gated potassium channel involved in severe inherited and drug-induced cardiac channelopathies, including the Long QT Syndrome. Firstly, the available structural data are integrated by providing a homology model for the closed state of the channel. Secondly, molecular dynamics combined with a network analysis revealed two distinct pathways coupling the voltage sensor domain with the pore domain. Interestingly, some LQTS-related mutations known to impair the activation/deactivation mechanism are distributed along the identified pathways, which thus suggests a microscopic interpretation of their role. Split channels simulations clarify a surprising feature of this channel, which is still able to gate when a cut is introduced between the voltage sensor domain and the neighboring helix S5. In summary, the presented results suggest possible activation/deactivation mechanisms of non-domain-swapped potassium channels that may aid in biomedical applications.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science. 1995;269:92–95. - PubMed
-
- Curran ME, et al. A molecular basis for cardiac arrhythmia: hERG mutations cause long QT syndrome. Cell. 1995;80:795–803. - PubMed
-
- Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006;440:463–469. - PubMed
-
- Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F. QT prolongation through hERG K+ channel blockade: current knowledge and strategies for the early prediction during drug development. Med. Res. Rev. 2005;25:133–166. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
